As the primary component of the amyloid plaques seen in the brains of Alzheimer patients, amyloid- (A) refers to peptides of 36–43 amino acids that are crucially involved in Alzheimer's disease. The amyloid precursor protein (APP), which is cut by specific enzymes to produce A, produces the peptides. Amyloid molecules can group together to create a variety of flexible, soluble oligomers.A amyloid-peptide buildup results from excessive A production or malfunctioning clearance mechanisms. Amyloid- forms diffuse and neuritic plaques in the parenchyma and blood vessels by self-aggregating into oligomers of various sizes. Strong synaptotoxins, proteasome inhibition, mitochondrial inhibition, alteration of intracellular Ca2+ levels, and induction of inflammatory processes are all characteristics of amyloid-oligomers and plaques. Neuronal dysfunction is also thought to be influenced by the loss of A's typical physiological functions.
| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V134182 | Donanemab (Mouse IgG2b) | Donanemab (Mouse IgG2b) is a chimeric antibody composed of a humanized variable region and a mouse IgG2b backbone. | |
|
V11347 | Emrusolmin (Anle138b) | 882697-00-9 | Anle138b is a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson's disease. |
|
V1315 | EUK 134 | 81065-76-1 | EUK 134 (EUK-134; EUK134), a synthetic and cell permeable superoxide dismutase (SOD)/catalase mimetic, is a novel antioxidant compound that exhibits potent antioxidant activities. |
|
V135957 | FITC-Ahx-β-Amyloid (1-42), (rat/mouse) tris | FITC-Ahx-β-Amyloid (1-42), (rat/mouse) tris is a fluorescently labeled (FITC) β-amyloid (1-42) (rat/mouse) product that can be used in Alzheimer's disease-related research, such as aggregation, fibrosis, cellular uptake, or imaging experiments. | |
|
V79435 | FITC-β-Ala-β-Amyloid (25-35) | FITC-β-Ala-β-Amyloid (25-35) is a fluorescent product labeled by FITC and may be utilized in the research of AD/Alzheimer's disease. | |
|
V79436 | FITC-β-Amyloid (25-35) | FITC-β-Amyloid (25-35) is FITC labeled β-Amyloid (25-35). | |
|
V71357 | Fmoc-Ala-Glu-Asn-Lys-NH2 | 220701-06-4 | Fmoc-Ala-Glu-Asn-Lys-NH2 is a selective asparagine endopeptidase AEP inhibitory peptide that can inhibit the cleavage of amyloid precursor protein APP. |
|
V2810 | FPS-ZM1 | 945714-67-0 | FPS-ZM1 is a potent and high-affinityRAGEspecific blocker with Kivalue of 25 nM. |
|
V118674 | GL-522 | 137407-62-6 | GL-522 (4-sulfocalix[8]arene) is an Aβ42 inhibitor. |
|
V71440 | Glp-amyloid-β (3-40) peptide (human) (AβpE3-40) | 161818-04-8 | Glp-Amyloid-β (3-40) Peptide (human) (AβpE3-40) is a small amount of pyroglutamic acid-modified Aβ extracted from 24-month-old amyloid precursor protein transgenic mice. |
|
V79396 | Glutaminyl Cyclase Inhibitor 5 | 3033553-63-5 | Glutaminyl Cyclase Inhibitor 5 (Compound 71) is a potent and specific inhibitor of human glutaminyl cyclase (hQC) with IC50 of 3.2 nM. |
|
V87776 | Glutaminyl Cyclase Inhibitor 6 | Glutaminyl Cyclase Inhibitor 6 (compound BI-43) is a secretory glutaminyl cyclase (sQC) and golgi-resident glutaminyl cyclase (gQC) inhibitor with IC50 values of 0.012 and 0.040 µM, respectively. | |
|
V104260 | Glutaminyl cyclases-IN-2 | Glutamine cyclase-IN-2 (Compound 27) is a potent glutamine cyclase inhibitor with IC50 of 0.08 μM. | |
|
V115305 | GLY-230 | 320777-05-7 | GLY-230 is an orally active compound. |
|
V136771 | Glycerophosphorylethanolamine sodium | 883288-78-6 | Glycerophosphorylethanolamine sodium is an active phosphodiester metabolite of phosphatidylethanolamine. |
|
V136912 | Grape Skin Extract | Grape Skin Extract is a substance extracted from grape skins, and its components include polyphenols. | |
|
V136979 | GSK-933776 | GSK-933776 is a humanized antibody expressed in CHO cells that targets amyloid β/Aβ. | |
|
V114392 | h-FTAA | 1352477-26-9 | h-FTAA is a luminescent conjugated oligothiophene (LCO) probe. |
|
V79691 | hAChE-IN-3 | 2983723-56-2 | hAChE-IN-3 (compounds 5c) is a potent and BBB (blood-brain barrier) permeable (penetrable) inhibitor of AChE, BuChE, MAO-B-IN-1 and BACE-1 with IC50s of 0.44, 0.08, 5.15 and 1, respectively. |
|
V79693 | hAChE-IN-5 | hAChE-IN-5 (compound 49) is a potent inhibitor of hAChE and hBuChE with IC50s of 0.17 μM and 0.17 μM, respectively. |